Myeloid cell-derived HIF-1α promotes control of leishmania major

Journal of Immunology

Volumn 197, Issue 10, 2016, Pages 4034-4041

  Schatz, Valentin ^a   Strüssmann, Yannic ^a   Mahnke, Alexander ^b   Schley, Gunnar ^b   Waldner, Maximilian ^b   Ritter, Uwe ^c   Wild, Jens ^a   Willam, Carsten ^b   Dehne, Nathalie ^d   Brüne, Bernhard ^d   McNiff, Jennifer M ^e   Colegio, Oscar R ^e   Bogdan, Christian ^a   Jantsch, Jonathan ^a,f  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Kliniken Dr Erler   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INNATE IMMUNITY; LEISHMANIA MAJOR; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN DEFECT; SKIN LEISHMANIASIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; SKIN;

ANIMALS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, INNATE; INTERFERON-GAMMA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARASITE LOAD; SKIN;

EID: 84994477337     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601080     Document Type: Article

References (70)

1. Semenza, G. L. 2012. Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
2. Kaelin Jr., W. G., and P. J. Ratcliffe. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30: 393-402.
3. Dehne, N., and B. Brüne. 2009. HIF-1 in the inflammatory microenvironment. Exp. Cell Res. 315: 1791-1797.
4. Palazon, A., A.W. Goldrath, V. Nizet, and R. S. Johnson. 2014. HIF transcription factors, inflammation, and immunity. Immunity 41: 518-528.
5. Jantsch, J., and J. Schödel. 2015. Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis. Immunobiology 220: 305-314.
6. Werth, N., C. Beerlage, C. Rosenberger, A. S. Yazdi, M. Edelmann, A. Amr, W. Bernhardt, C. von Eiff, K. Becker, A. Schäfer, et al. 2010. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 5: e11576.
7. Frede, S., C. Stockmann, P. Freitag, and J. Fandrey. 2006. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem. J. 396: 517-527.
8. Tannahill, G. M., A. M. Curtis, J. Adamik, E. M. Palsson-McDermott, A. F. McGettrick, G. Goel, C. Frezza, N. J. Bernard, B. Kelly, N. H. Foley, et al. 2013. Succinate is an inflammatory signal that induces IL-1b through HIF-1a. Nature 496: 238-242.
9. Siegert, I., J. Schödel, M. Nairz, V. Schatz, K. Dettmer, C. Dick, J. Kalucka, K. Franke, M. Ehrenschwender, G. Schley, et al. 2015. Ferritin-mediated iron sequestration stabilizes hypoxia-inducible factor-1a upon LPS activation in the presence of ample oxygen. Cell Rep. 13: 2048-2055.
10. Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A. S. Zinkernagel, V. Nizet, R. S. Johnson, G. G. Haddad, and M. Karin. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811.
11. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Förster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
12. Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E. A. Theodorakis, R. L. Gallo, N. Hurtado-Ziola, V. Nizet, and R. S. Johnson. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115: 1806-1815.
13. Berger, E. A., S. A. McClellan, K. S. Vistisen, and L. D. Hazlett. 2013. HIF-1a is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog. 9: e1003457.
14. Cardoso, M. S., T. M. Silva, M. Resende, R. Appelberg, and M. Borges. 2015. Lack of the transcription factor hypoxia-inducible factor 1a (HIF-1a) in macrophages accelerates the necrosis of Mycobacterium avium-induced granulomas. Infect. Immun. 83: 3534-3544.
15. Shepardson, K. M., A. Jhingran, A. Caffrey, J. J. Obar, B. T. Suratt, B. L. Berwin, T. M. Hohl, and R. A. Cramer. 2014. Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection. PLoS Pathog. 10: e1004378.
16. Cheng, S. C., J. Quintin, R. A. Cramer, K. M. Shepardson, S. Saeed, V. Kumar, E. J. Giamarellos-Bourboulis, J. H. Martens, N. A. Rao, A. Aghajanirefah, et al. 2014. mTOR-and HIF-1a-mediated aerobic glycolysis as metabolic basis for trained immunity. [Published erratum appears in 2014 Science 346: aaa1503.] Science 345: 1250684.
17. Metheni, M., N. Echebli, M. Chaussepied, C. Ransy, C. Chéreau, K. Jensen, E. Glass, F. Batteux, F. Bouillaud, and G. Langsley. 2014. The level of H2O2 type oxidative stress regulates virulence of Theileria-transformed leukocytes. Cell. Microbiol. 16: 269-279.
18. Wiley, M., K. R. Sweeney, D. A. Chan, K. M. Brown, C. McMurtrey, E. W. Howard, A. J. Giaccia, and I. J. Blader. 2010. Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling. J. Biol. Chem. 285: 26852-26860.
19. Singh, A. K., C. Mukhopadhyay, S. Biswas, V. K. Singh, and C. K. Mukhopadhyay. 2012. Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage. PLoS One 7: e38489.
20. Hammami, A., T. Charpentier, M. Smans, and S. Stäger. 2015. IRF-5-mediated inflammation limits CD8+ T cell expansion by inducing HIF-1a and impairing dendritic cell functions during Leishmania infection. PLoS Pathog. 11: e1004938.
21. Araújo, A. P., W. W. Arrais-Silva, and S. Giorgio. 2012. Infection by Leishmania amazonensis in mice: a potential model for chronic hypoxia. Acta Histochem. 114: 797-804.
22. Araujo, V. C., K. F. Fukutani, E. T. Oshiro, P. O. Rodrigues, Y. S. Rizk, C. A. Carollo, and C. C. Arruda. 2015. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis. Exp. Parasitol. 157: 138-144.
23. Lemaire, J., G. Mkannez, F. Z. Guerfali, C. Gustin, H. Attia, R. M. Sghaier, K. Dellagi, D. Laouini, and P. Renard, Sysco-Consortium. 2013. MicroRNA expression profile in human macrophages in response to Leishmania major infection. PLoS Negl. Trop. Dis. 7: e2478.
24. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144: 4794-4797.
25. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Röllinghoff, I. Gresser, and C. Bogdan. 1998. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8: 77-87.
26. Mahnke, A., R. J. Meier, V. Schatz, J. Hofmann, K. Castiglione, U. Schleicher, O. S. Wolfbeis, C. Bogdan, and J. Jantsch. 2014. Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages. J. Invest. Dermatol. 134: 2339-2346.
27. Schleicher, U., K. Paduch, A. Debus, S. Obermeyer, T. König, J. C. Kling, E. Ribechini, D. Dudziak, D. Mougiakakos, P. J. Murray, et al. 2016. TNFmediated restriction of arginase 1 expression in myeloid cells triggers type 2 NO synthase activity at the site of infection. Cell Rep. 15: 1062-1075.
28. Melillo, G., L. S. Taylor, A. Brooks, T. Musso, G. W. Cox, and L. Varesio. 1997. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272: 12236-12243.
29. Melillo, G., T. Musso, A. Sica, L. S. Taylor, G. W. Cox, and L. Varesio. 1995. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182: 1683-1693.
30. Jantsch, J., M. Wiese, J. Schödel, K. Castiglione, J. Gläsner, S. Kolbe, D. Mole, U. Schleicher, K. U. Eckardt, M. Hensel, et al. 2011. Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1a (HIF1A) and result in differential HIF1A-dependent gene expression. J. Leukoc. Biol. 90: 551-562.
31. Schley, G., B. Klanke, J. Schödel, S. Kröning, G. Türkoglu, A. Beyer, Y. Hagos, K. Amann, B. C. Burckhardt, N. Burzlaff, et al. 2012. Selective stabilization of HIF-1a in renal tubular cells by 2-oxoglutarate analogues. Am. J. Pathol. 181: 1595-1606.
32. Solbach, W., K. Forberg, E. Kammerer, C. Bogdan, and M. Röllinghoff. 1986. Suppressive effect of cyclosporin A on the development of Leishmania tropicainduced lesions in genetically susceptible BALB/c mice. J. Immunol. 137: 702-707.
33. Stenger, S., N. Donhauser, H. Thüring, M. Röllinghoff, and C. Bogdan. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183: 1501-1514.
34. Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60: 4010-4015.
35. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
36. Weigert, A., B. Weichand, D. Sekar, W. Sha, C. Hahn, J. Mora, S. Ley, S. Essler, N. Dehne, and B. Brüne. 2012. HIF-1a is a negative regulator of plasmacytoid DC development in vitro and in vivo. Blood 120: 3001-3006.
37. Roda, J. M., L. A. Sumner, R. Evans, G. S. Phillips, C. B. Marsh, and T. D. Eubank. 2011. Hypoxia-inducible factor-2a regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. J. Immunol. 187: 1970-1976.
38. Schleicher, U., and C. Bogdan. 2009. Generation, culture and flow-cytometric characterization of primary mouse macrophages. Methods Mol. Biol. 531: 203-224.
39. Siegert, I., V. Schatz, A. T. Prechtel, A. Steinkasserer, C. Bogdan, and J. Jantsch. 2014. Electroporation of siRNA into mouse bone marrow-derived macrophages and dendritic cells. Methods Mol. Biol. 1121: 111-119.
40. Wiese, M., K. Castiglione, M. Hensel, U. Schleicher, C. Bogdan, and J. Jantsch. 2010. Small interfering RNA (siRNA) delivery into murine bone marrow-derived macrophages by electroporation. J. Immunol. Methods 353: 102-110.
41. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178: 605-613.
42. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407-2412.
43. Peyssonnaux, C., A. T. Boutin, A. S. Zinkernagel, V. Datta, V. Nizet, and R. S. Johnson. 2008. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J. Invest. Dermatol. 128: 1964-1968.
44. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2: 845-858.
45. Mougneau, E., F. Bihl, and N. Glaichenhaus. 2011. Cell biology and immunology of Leishmania. Immunol. Rev. 240: 286-296.
46. Olekhnovitch, R., and P. Bousso. 2015. Induction, propagation, and activity of host nitric oxide: lessons from Leishmania infection. Trends Parasitol. 31: 653-664.
47. Kaye, P., and P. Scott. 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 9: 604-615.
48. Ghosh, S., S. Bhattacharyya, M. Sirkar, G. S. Sa, T. Das, D. Majumdar, S. Roy, and S. Majumdar. 2002. Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect. Immun. 70: 6828-6838.
49. Gregory, D. J., M. Godbout, I. Contreras, G. Forget, and M. Olivier. 2008. A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression. Eur. J. Immunol. 38: 1071-1081.
50. Ben-Othman, R., L. Guizani-Tabbane, and K. Dellagi. 2008. Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages. Mol. Immunol. 45: 3222-3229.
51. Wang, Z. E., S. L. Reiner, S. Zheng, D. K. Dalton, and R. M. Locksley. 1994. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J. Exp. Med. 179: 1367-1371.
52. Wilhelm, P., U. Ritter, S. Labbow, N. Donhauser, M. Röllinghoff, C. Bogdan, and H. Körner. 2001. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166: 4012-4019.
53. Muraille, E., C. De Trez, M. Brait, P. De Baetselier, O. Leo, and Y. Carlier. 2003. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170: 4237-4241.
54. Kropf, P., M. A. Freudenberg, M. Modolell, H. P. Price, S. Herath, S. Antoniazi, C. Galanos, D. F. Smith, and I. Müller. 2004. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72: 1920-1928.
55. Liese, J., U. Schleicher, and C. Bogdan. 2007. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur. J. Immunol. 37: 3424-3434.
56. Schoenen, H., A. Huber, N. Sonda, S. Zimmermann, J. Jantsch, B. Lepenies, V. Bronte, and R. Lang. 2014. Differential control of Mincle-dependent cord factor recognition and macrophage responses by the transcription factors C/EBPb and HIF1a. J. Immunol. 193: 3664-3675.
57. Arrais-Silva, W. W., V. A. Paffaro, Jr., A. T. Yamada, and S. Giorgio. 2005. Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis. Exp. Mol. Pathol. 78: 49-54.
58. Braverman, J., K. M. Sogi, D. Benjamin, D. K. Nomura, and S. A. Stanley. 2016. HIF-1a is an essential mediator of IFN-g-dependent immunity to mycobacterium tuberculosis. J. Immunol. 197: 1287-1297.
59. Degrossoli, A., M. C. Bosetto, C. B. Lima, and S. Giorgio. 2007. Expression of hypoxia-inducible factor 1alpha in mononuclear phagocytes infected with Leishmania amazonensis. Immunol. Lett. 114: 119-125.
60. Westrop, G. D., R. A. Williams, L. Wang, T. Zhang, D. G. Watson, A. M. Silva, and G. H. Coombs. 2015. Metabolomic analyses of Leishmania reveal multiple species differences and large differences in amino acid metabolism. PLoS One 10: e0136891.
61. Zhang, W. W., L. I. McCall, and G. Matlashewski. 2013. Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani. Eukaryot. Cell 12: 70-77.
62. O'Neill, L. A., and E. J. Pearce. 2016. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213: 15-23.
63. Ganeshan, K., and A. Chawla. 2014. Metabolic regulation of immune responses. Annu. Rev. Immunol. 32: 609-634.
64. Zinkernagel, A. S., C. Peyssonnaux, R. S. Johnson, and V. Nizet. 2008. Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J. Infect. Dis. 197: 214-217.
65. Albina, J. E., W. L. Henry, Jr., B. Mastrofrancesco, B. A. Martin, and J. S. Reichner. 1995. Macrophage activation by culture in an anoxic environment. J. Immunol. 155: 4391-4396.
66. Wiese, M., R. G. Gerlach, I. Popp, J. Matuszak, M. Mahapatro, K. Castiglione, D. Chakravortty, C. Willam, M. Hensel, C. Bogdan, and J. Jantsch. 2012. Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages. Infect. Immun. 80: 1455-1466.
67. Robinson, M. A., S. W. Tuttle, C. M. Otto, and C. J. Koch. 2010. pO(2)-dependent NO production determines OPPC activity in macrophages. Free Radic. Biol. Med. 48: 189-195.
68. Fecher, R. A., M. C. Horwath, D. Friedrich, J. Rupp, and G. S. Deepe, Jr. 2016. Inverse correlation between IL-10 and HIF-1a in macrophages infected with Histoplasma capsulatum. J. Immunol. 197: 565-579.
69. Matak, P., M. Heinis, J. R. Mathieu, R. Corriden, S. Cuvellier, S. Delga, R. Mounier, A. Rouquette, J. Raymond, D. Lamarque, et al. 2015. Myeloid HIF-1 is protective in Helicobacter pylori-mediated gastritis. J. Immunol. 194: 3259-3266.
70. Weinkopff, T., C. Konradt, D. A. Christian, D. E. Discher, C. A. Hunter, and P. Scott. 2016. Leishmania major infection-induced VEGF-A/VEGFR-2 signaling promotes lymphangiogenesis that controls disease. J. Immunol. 197: 1823-1831.